Cargando…

Facial palsy as a manifestation of COVID‐19: A systematic review of cases

BACKGROUND AND AIMS: Facial palsy is a rare complication of the COVID‐19 infection. Herein, we conducted a systematic review of all published cases of facial palsy post‐COVID‐19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurshid, Aiman, Khurshid, Maman, Sohail, Aruba, Raza, Imran Mansoor, Ahsan, Muhammad Khubab, Alam Shah, Mir Umer Farooq, Taseer, Anab Rehan, Nashwan, Abdulqadir J., Ullah, Irfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616168/
https://www.ncbi.nlm.nih.gov/pubmed/36320650
http://dx.doi.org/10.1002/hsr2.887
_version_ 1784820592264871936
author Khurshid, Aiman
Khurshid, Maman
Sohail, Aruba
Raza, Imran Mansoor
Ahsan, Muhammad Khubab
Alam Shah, Mir Umer Farooq
Taseer, Anab Rehan
Nashwan, Abdulqadir J.
Ullah, Irfan
author_facet Khurshid, Aiman
Khurshid, Maman
Sohail, Aruba
Raza, Imran Mansoor
Ahsan, Muhammad Khubab
Alam Shah, Mir Umer Farooq
Taseer, Anab Rehan
Nashwan, Abdulqadir J.
Ullah, Irfan
author_sort Khurshid, Aiman
collection PubMed
description BACKGROUND AND AIMS: Facial palsy is a rare complication of the COVID‐19 infection. Herein, we conducted a systematic review of all published cases of facial palsy post‐COVID‐19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of facial palsy in COVID‐19 patients, its detection, effective treatment plan, and prognosis of the condition. METHODS: We searched PubMed, Google Scholar, and Directory of Open Access Journals (DOAJ) from December 1, 2019 to September 21, 2021. RESULTS: We included 49 studies bearing accounts of 75 cases who had facial palsy. The mean age of patients was 42.9 ± 19.59 years, with a male‐to‐female ratio of 8:7. The majority of the cases were reported from Brazil (n = 14), USA (n = 9), Turkey (n = 9), and Spain (n = 9). Noticeably, 30.14% of COVID‐19 patients were diagnosed with Guillain‐Barré syndrome. In total, 22.97% of patients complained of bilateral facial paralysis (n = 17), whereas ipsilateral paralysis was observed in 77.03% (n = 57). These were common complaints of Lagophthalmos, otalgia, facial drooping, dysarthria, and compromised forehead wrinkling. The treatment regimen mainly included the use of corticosteroids (n = 51) (69.86%), antivirals (n = 23) (31.51%), IVIG (n = 18) (24.66%), antibiotics (n = 13) (17.81%), antiretroviral (n = 9) (12.33%), and antimalarial (n = 8) (10.96%) medications. In all, 35.62% of patients (n = 26) adhered to a combination of antiviral and corticosteroid‐based therapy. Positive treatment outcomes were observed in 83.58% (n = 56) of cases. In contrast, 10 patients (14.93%) showed nonsignificant recovery, out of which 3 (4.48%) died from the disease. CONCLUSION: The association of facial palsy with COVID‐19 is controversial and therefore requires further investigation and published work to confirm a causal relationship. However, physicians should not overlook the likelihood of facial palsy post‐COVID‐19 infection and treat it accordingly.
format Online
Article
Text
id pubmed-9616168
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96161682022-10-31 Facial palsy as a manifestation of COVID‐19: A systematic review of cases Khurshid, Aiman Khurshid, Maman Sohail, Aruba Raza, Imran Mansoor Ahsan, Muhammad Khubab Alam Shah, Mir Umer Farooq Taseer, Anab Rehan Nashwan, Abdulqadir J. Ullah, Irfan Health Sci Rep Narrative Review BACKGROUND AND AIMS: Facial palsy is a rare complication of the COVID‐19 infection. Herein, we conducted a systematic review of all published cases of facial palsy post‐COVID‐19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of facial palsy in COVID‐19 patients, its detection, effective treatment plan, and prognosis of the condition. METHODS: We searched PubMed, Google Scholar, and Directory of Open Access Journals (DOAJ) from December 1, 2019 to September 21, 2021. RESULTS: We included 49 studies bearing accounts of 75 cases who had facial palsy. The mean age of patients was 42.9 ± 19.59 years, with a male‐to‐female ratio of 8:7. The majority of the cases were reported from Brazil (n = 14), USA (n = 9), Turkey (n = 9), and Spain (n = 9). Noticeably, 30.14% of COVID‐19 patients were diagnosed with Guillain‐Barré syndrome. In total, 22.97% of patients complained of bilateral facial paralysis (n = 17), whereas ipsilateral paralysis was observed in 77.03% (n = 57). These were common complaints of Lagophthalmos, otalgia, facial drooping, dysarthria, and compromised forehead wrinkling. The treatment regimen mainly included the use of corticosteroids (n = 51) (69.86%), antivirals (n = 23) (31.51%), IVIG (n = 18) (24.66%), antibiotics (n = 13) (17.81%), antiretroviral (n = 9) (12.33%), and antimalarial (n = 8) (10.96%) medications. In all, 35.62% of patients (n = 26) adhered to a combination of antiviral and corticosteroid‐based therapy. Positive treatment outcomes were observed in 83.58% (n = 56) of cases. In contrast, 10 patients (14.93%) showed nonsignificant recovery, out of which 3 (4.48%) died from the disease. CONCLUSION: The association of facial palsy with COVID‐19 is controversial and therefore requires further investigation and published work to confirm a causal relationship. However, physicians should not overlook the likelihood of facial palsy post‐COVID‐19 infection and treat it accordingly. John Wiley and Sons Inc. 2022-10-28 /pmc/articles/PMC9616168/ /pubmed/36320650 http://dx.doi.org/10.1002/hsr2.887 Text en © 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Narrative Review
Khurshid, Aiman
Khurshid, Maman
Sohail, Aruba
Raza, Imran Mansoor
Ahsan, Muhammad Khubab
Alam Shah, Mir Umer Farooq
Taseer, Anab Rehan
Nashwan, Abdulqadir J.
Ullah, Irfan
Facial palsy as a manifestation of COVID‐19: A systematic review of cases
title Facial palsy as a manifestation of COVID‐19: A systematic review of cases
title_full Facial palsy as a manifestation of COVID‐19: A systematic review of cases
title_fullStr Facial palsy as a manifestation of COVID‐19: A systematic review of cases
title_full_unstemmed Facial palsy as a manifestation of COVID‐19: A systematic review of cases
title_short Facial palsy as a manifestation of COVID‐19: A systematic review of cases
title_sort facial palsy as a manifestation of covid‐19: a systematic review of cases
topic Narrative Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616168/
https://www.ncbi.nlm.nih.gov/pubmed/36320650
http://dx.doi.org/10.1002/hsr2.887
work_keys_str_mv AT khurshidaiman facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT khurshidmaman facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT sohailaruba facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT razaimranmansoor facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT ahsanmuhammadkhubab facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT alamshahmirumerfarooq facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT taseeranabrehan facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT nashwanabdulqadirj facialpalsyasamanifestationofcovid19asystematicreviewofcases
AT ullahirfan facialpalsyasamanifestationofcovid19asystematicreviewofcases